Pre-order Enquiry
Request Free Sample
Global Chronic Myeloid Leukemia (CML) Treatment Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-16989502 | Publishing Date : 18-Dec-2020 | No. of pages : 114
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Chronic Myeloid Leukemia (CML) Treatment Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Chronic Myeloid Leukemia (CML) Treatment1.1 Chronic Myeloid Leukemia (CML) Treatment Market Overview
1.1.1 Chronic Myeloid Leukemia (CML) Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 Global Chronic Myeloid Leukemia (CML) Treatment Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Region (2015-2026)
1.4 Global Chronic Myeloid Leukemia (CML) Treatment Historic Market Size by Region (2015-2020)
1.5 Global Chronic Myeloid Leukemia (CML) Treatment Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2026)
1.6.1 North America Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2026)
1.6.2 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2026)
1.6.3 China Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2026)
1.6.5 Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2026)
2 Chronic Myeloid Leukemia (CML) Treatment Market Overview by Type
2.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Chronic Myeloid Leukemia (CML) Treatment Historic Market Size by Type (2015-2020)
2.3 Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Type (2021-2026)
2.4 Targeted Therapy
2.5 Chemotherapy
2.6 Radiation Therapy
2.7 Splenectomy
2.8 Stem Cell Transplant
3 Chronic Myeloid Leukemia (CML) Treatment Market Overview by Application
3.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Chronic Myeloid Leukemia (CML) Treatment Historic Market Size by Application (2015-2020)
3.3 Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Application (2021-2026)
3.4 Hospitals
3.5 Clinic
3.6 Others
4 Global Chronic Myeloid Leukemia (CML) Treatment Competition Analysis by Players
4.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Myeloid Leukemia (CML) Treatment as of 2019)
4.3 Date of Key Manufacturers Enter into Chronic Myeloid Leukemia (CML) Treatment Market
4.4 Global Top Players Chronic Myeloid Leukemia (CML) Treatment Headquarters and Area Served
4.5 Key Players Chronic Myeloid Leukemia (CML) Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Chronic Myeloid Leukemia (CML) Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Novartis AG
5.1.1 Novartis AG Profile
5.1.2 Novartis AG Main Business and Company’s Total Revenue
5.1.3 Novartis AG Products, Services and Solutions
5.1.4 Novartis AG Revenue (US$ Million) (2015-2020)
5.1.5 Novartis AG Recent Development and Reaction to Covid-19
5.2 Bristol-Myers Squibb
5.2.1 Bristol-Myers Squibb Profile
5.2.2 Bristol-Myers Squibb Main Business and Company’s Total Revenue
5.2.3 Bristol-Myers Squibb Products, Services and Solutions
5.2.4 Bristol-Myers Squibb Revenue (US$ Million) (2015-2020)
5.2.5 Bristol-Myers Squibb Recent Development and Reaction to Covid-19
5.3 Teva Pharmaceuticals Industries Ltd.
5.5.1 Teva Pharmaceuticals Industries Ltd. Profile
5.3.2 Teva Pharmaceuticals Industries Ltd. Main Business and Company’s Total Revenue
5.3.3 Teva Pharmaceuticals Industries Ltd. Products, Services and Solutions
5.3.4 Teva Pharmaceuticals Industries Ltd. Revenue (US$ Million) (2015-2020)
5.3.5 ARIAD Pharmaceuticals, Inc. Recent Development and Reaction to Covid-19
5.4 ARIAD Pharmaceuticals, Inc.
5.4.1 ARIAD Pharmaceuticals, Inc. Profile
5.4.2 ARIAD Pharmaceuticals, Inc. Main Business and Company’s Total Revenue
5.4.3 ARIAD Pharmaceuticals, Inc. Products, Services and Solutions
5.4.4 ARIAD Pharmaceuticals, Inc. Revenue (US$ Million) (2015-2020)
5.4.5 ARIAD Pharmaceuticals, Inc. Recent Development and Reaction to Covid-19
5.5 Pfizer, Inc.
5.5.1 Pfizer, Inc. Profile
5.5.2 Pfizer, Inc. Main Business and Company’s Total Revenue
5.5.3 Pfizer, Inc. Products, Services and Solutions
5.5.4 Pfizer, Inc. Revenue (US$ Million) (2015-2020)
5.5.5 Pfizer, Inc. Recent Development and Reaction to Covid-19
5.6 Hospira, Inc.
5.6.1 Hospira, Inc. Profile
5.6.2 Hospira, Inc. Main Business and Company’s Total Revenue
5.6.3 Hospira, Inc. Products, Services and Solutions
5.6.4 Hospira, Inc. Revenue (US$ Million) (2015-2020)
5.6.5 Hospira, Inc. Recent Development and Reaction to Covid-19
5.7 Prism Pharmaceuticals
5.7.1 Prism Pharmaceuticals Profile
5.7.2 Prism Pharmaceuticals Main Business and Company’s Total Revenue
5.7.3 Prism Pharmaceuticals Products, Services and Solutions
5.7.4 Prism Pharmaceuticals Revenue (US$ Million) (2015-2020)
5.7.5 Prism Pharmaceuticals Recent Development and Reaction to Covid-19
5.8 Incyte Corporation
5.8.1 Incyte Corporation Profile
5.8.2 Incyte Corporation Main Business and Company’s Total Revenue
5.8.3 Incyte Corporation Products, Services and Solutions
5.8.4 Incyte Corporation Revenue (US$ Million) (2015-2020)
5.8.5 Incyte Corporation Recent Development and Reaction to Covid-19
5.9 Bio-Path Holdings
5.9.1 Bio-Path Holdings Profile
5.9.2 Bio-Path Holdings Main Business and Company’s Total Revenue
5.9.3 Bio-Path Holdings Products, Services and Solutions
5.9.4 Bio-Path Holdings Revenue (US$ Million) (2015-2020)
5.9.5 Bio-Path Holdings Recent Development and Reaction to Covid-19
5.10 Stragen Pharma SA
5.10.1 Stragen Pharma SA Profile
5.10.2 Stragen Pharma SA Main Business and Company’s Total Revenue
5.10.3 Stragen Pharma SA Products, Services and Solutions
5.10.4 Stragen Pharma SA Revenue (US$ Million) (2015-2020)
5.10.5 Stragen Pharma SA Recent Development and Reaction to Covid-19
5.11 Otsuka Pharmaceutical Co., Ltd.
5.11.1 Otsuka Pharmaceutical Co., Ltd. Profile
5.11.2 Otsuka Pharmaceutical Co., Ltd. Main Business and Company’s Total Revenue
5.11.3 Otsuka Pharmaceutical Co., Ltd. Products, Services and Solutions
5.11.4 Otsuka Pharmaceutical Co., Ltd. Revenue (US$ Million) (2015-2020)
5.11.5 Otsuka Pharmaceutical Co., Ltd. Recent Development and Reaction to Covid-19
6 North America Chronic Myeloid Leukemia (CML) Treatment by Players and by Application
6.1 North America Chronic Myeloid Leukemia (CML) Treatment Market Size and Market Share by Players (2015-2020)
6.2 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)
7 Europe Chronic Myeloid Leukemia (CML) Treatment by Players and by Application
7.1 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size and Market Share by Players (2015-2020)
7.2 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)
8 China Chronic Myeloid Leukemia (CML) Treatment by Players and by Application
8.1 China Chronic Myeloid Leukemia (CML) Treatment Market Size and Market Share by Players (2015-2020)
8.2 China Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)
9 Rest of Asia Pacific Chronic Myeloid Leukemia (CML) Treatment by Players and by Application
9.1 Rest of Asia Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)
10 Latin America Chronic Myeloid Leukemia (CML) Treatment by Players and by Application
10.1 Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size and Market Share by Players (2015-2020)
10.2 Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)
11 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment by Players and by Application
11.1 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)
12 Chronic Myeloid Leukemia (CML) Treatment Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
List of Figures, Tables and Charts Available in Global Chronic Myeloid Leukemia (CML) Treatment Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Chronic Myeloid Leukemia (CML) Treatment Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026
Table 2. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Region (2015-2020) (US$ Million)
Table 3. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Share by Region (2015-2020)
Table 4. Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Region (2021-2026) (US$ Million)
Table 5. Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size Share by Region (2021-2026)
Table 6. Global Chronic Myeloid Leukemia (CML) Treatment Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026
Table 7. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (US$ Million)
Table 8. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Type (2015-2020)
Table 9. Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 10. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Type (2021-2026)
Table 11. Global Chronic Myeloid Leukemia (CML) Treatment Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026
Table 12. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (US$ Million)
Table 13. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Application (2015-2020)
Table 14. Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 15. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Application (2021-2026)
Table 16. Global Chronic Myeloid Leukemia (CML) Treatment Revenue (US$ Million) by Players (2015-2020)
Table 17. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Players (2015-2020)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Myeloid Leukemia (CML) Treatment as of 2019)
Table 19. Date of Key Manufacturers Enter into Chronic Myeloid Leukemia (CML) Treatment Market
Table 20. Global Chronic Myeloid Leukemia (CML) Treatment Top Players Headquarters and Area Served
Table 21. Chronic Myeloid Leukemia (CML) Treatment Product Solution and Service
Table 22. Global Chronic Myeloid Leukemia (CML) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Novartis AG Basic Information List
Table 25. Novartis AG Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 26. Novartis AG Chronic Myeloid Leukemia (CML) Treatment Products, Services and Solutions
Table 27. Revenue (Million US$) in Chronic Myeloid Leukemia (CML) Treatment Business of Novartis AG (2015-2020)
Table 28. Novartis AG Recent Developments
Table 29. Bristol-Myers Squibb Basic Information List
Table 30. Bristol-Myers Squibb Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 31. Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Products, Services and Solutions
Table 32. Revenue (Million US$) in Chronic Myeloid Leukemia (CML) Treatment Business of Bristol-Myers Squibb (2015-2020)
Table 33. Bristol-Myers Squibb Recent Developments
Table 34. Teva Pharmaceuticals Industries Ltd. Basic Information List
Table 35. Teva Pharmaceuticals Industries Ltd. Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 36. Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Products, Services and Solutions
Table 37. Revenue (Million US$) in Chronic Myeloid Leukemia (CML) Treatment Business of Teva Pharmaceuticals Industries Ltd. (2015-2020)
Table 38. Teva Pharmaceuticals Industries Ltd. Recent Developments
Table 39. ARIAD Pharmaceuticals, Inc. Basic Information List
Table 40. ARIAD Pharmaceuticals, Inc. Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 41. ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Products, Services and Solutions
Table 42. Revenue (Million US$) in Chronic Myeloid Leukemia (CML) Treatment Business of ARIAD Pharmaceuticals, Inc. (2015-2020)
Table 43. ARIAD Pharmaceuticals, Inc. Recent Developments
Table 44. Pfizer, Inc. Basic Information List
Table 45. Pfizer, Inc. Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 46. Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Products, Services and Solutions
Table 47. Revenue (Million US$) in Chronic Myeloid Leukemia (CML) Treatment Business of Pfizer, Inc. (2015-2020)
Table 48. Pfizer, Inc. Recent Developments
Table 49. Hospira, Inc. Basic Information List
Table 50. Hospira, Inc. Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 51. Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Products, Services and Solutions
Table 52. Revenue (Million US$) in Chronic Myeloid Leukemia (CML) Treatment Business of Hospira, Inc. (2015-2020)
Table 53. Hospira, Inc. Recent Developments
Table 54. Prism Pharmaceuticals Basic Information List
Table 55. Prism Pharmaceuticals Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 56. Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Products, Services and Solutions
Table 57. Revenue (Million US$) in Chronic Myeloid Leukemia (CML) Treatment Business of Prism Pharmaceuticals (2015-2020)
Table 58. Prism Pharmaceuticals Recent Developments
Table 59. Incyte Corporation Basic Information List
Table 60. Incyte Corporation Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 61. Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Products, Services and Solutions
Table 62. Revenue (Million US$) in Chronic Myeloid Leukemia (CML) Treatment Business of Incyte Corporation (2015-2020)
Table 63. Incyte Corporation Recent Developments
Table 64. Bio-Path Holdings Basic Information List
Table 65. Bio-Path Holdings Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 66. Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Products, Services and Solutions
Table 67. Revenue (Million US$) in Chronic Myeloid Leukemia (CML) Treatment Business of Bio-Path Holdings (2015-2020)
Table 68. Bio-Path Holdings Recent Developments
Table 69. Stragen Pharma SA Basic Information List
Table 70. Stragen Pharma SA Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 71. Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Products, Services and Solutions
Table 72. Revenue (Million US$) in Chronic Myeloid Leukemia (CML) Treatment Business of Stragen Pharma SA (2015-2020)
Table 73. Stragen Pharma SA Recent Developments
Table 74. Otsuka Pharmaceutical Co., Ltd. Basic Information List
Table 75. Otsuka Pharmaceutical Co., Ltd. Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 76. Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Products, Services and Solutions
Table 77. Revenue (Million US$) in Chronic Myeloid Leukemia (CML) Treatment Business of Otsuka Pharmaceutical Co., Ltd. (2015-2020)
Table 78. Otsuka Pharmaceutical Co., Ltd. Recent Developments
Table 79. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (Million US$)
Table 80. North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Players (2015-2020) (US$ Million)
Table 81. North America Chronic Myeloid Leukemia (CML) Treatment Market Size Share by Players (2015-2020)
Table 82. North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (US$ Million)
Table 83. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Players (2015-2020) (US$ Million)
Table 84. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size Share by Players (2015-2020)
Table 85. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (US$ Million)
Table 86. China Chronic Myeloid Leukemia (CML) Treatment Market Size by Players (2015-2020) (US$ Million)
Table 87. China Chronic Myeloid Leukemia (CML) Treatment Market Size Share by Players (2015-2020) (US$ Million)
Table 88. China Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (US$ Million)
Table 89. Rest of Asia Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Players (2015-2020) (US$ Million)
Table 90. Rest of Asia Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size Share by Players (2015-2020) (US$ Million)
Table 91. Rest of Asia Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (US$ Million)
Table 92. Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Players (2015-2020) (US$ Million)
Table 93. Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size Share by Players (2015-2020) (US$ Million)
Table 94. Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (US$ Million)
Table 95. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Players (2015-2020) (US$ Million)
Table 96. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size Share by Players (2015-2020) (US$ Million)
Table 97. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (US$ Million)
Table 98. Market Top Trends
Table 99. Key Drivers: Impact Analysis (2021-2026)
Table 100. Key Challenges
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Myeloid Leukemia (CML) Treatment Market Size (US$ Million) Status and Outlook (2015-2026)
Figure 2. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Regions: 2020 VS 2026
Figure 3. North America Chronic Myeloid Leukemia (CML) Treatment Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 4. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 5. China Chronic Myeloid Leukemia (CML) Treatment Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 6. Rest of Asia Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 7. Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 8. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 9. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Type in 2020 & 2026
Figure 10. Targeted Therapy Market Size (US$ Million) YoY Growth (2015-2026)
Figure 11. Chemotherapy Market Size (US$ Million) YoY Growth (2015-2026)
Figure 12. Radiation Therapy Market Size (US$ Million) YoY Growth (2015-2026)
Figure 13. Splenectomy Market Size (US$ Million) YoY Growth (2015-2026)
Figure 14. Stem Cell Transplant Market Size (US$ Million) YoY Growth (2015-2026)
Figure 15. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Share by Application in 2020 & 2026
Figure 16. Chronic Myeloid Leukemia (CML) Treatment Market Size (US$ Million) and Growth Rate in Hospitals (2015-2020)
Figure 17. Chronic Myeloid Leukemia (CML) Treatment Market Size (US$ Million) and Growth Rate in Clinic (2015-2020)
Figure 18. Chronic Myeloid Leukemia (CML) Treatment Market Size (US$ Million) and Growth Rate in Others (2015-2020)
Figure 19. Chronic Myeloid Leukemia (CML) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Top 5 and Top 10 Players Chronic Myeloid Leukemia (CML) Treatment Market Share in 2019
Figure 21. Europe Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Application (2015-2020)
Figure 22. China Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Application (2015-2020)
Figure 23. Rest of Asia Pacific Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Application (2015-2020)
Figure 24. Latin America Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Application (2015-2020)
Figure 25. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Application (2015-2020)
Figure 26. Porter's Five Forces Analysis
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Keyplayers in Global Chronic Myeloid Leukemia (CML) Treatment Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
Novartis AGBristol-Myers Squibb
Teva Pharmaceuticals Industries Ltd.
ARIAD Pharmaceuticals, Inc.
Pfizer, Inc.
Hospira, Inc.
Prism Pharmaceuticals
Incyte Corporation
Bio-Path Holdings
Stragen Pharma SA
Otsuka Pharmaceutical Co., Ltd.
